Kohli Prashantinsider trades

In SEC Form 4 filings, Kohli Prashant is listed as Chief Executive Officer of Grace Therapeutics, Inc. (GRCE). In the last 90 days, Kohli Prashant bought $214K of Grace Therapeutics, Inc. (GRCE) on the open market and sold none. The purchase was $214K of Grace Therapeutics, Inc. (GRCE) on Sep 9. Took part in a cluster buy; the latest at Grace Therapeutics, Inc. (GRCE), where 2 insiders bought within 14 days, ending Sep 21.

Companies and roles

Company	Role	Transactions	Last filed
GRCEGrace Therapeutics, Inc.	Chief Executive Officer	2	Sep 10

Cluster buys

GRCE: 2 insiders bought $266.4K between Sep 8 – Sep 21.

Form 4 historysince 2026-09-01

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
GRCEGrace Therapeutics, Inc.	Sep 9	Sep 10	P	100,000	$2.14	Purchase +$214,000	121,357	No	Form 4
GRCEGrace Therapeutics, Inc.	Aug 28	Sep 1	A · derivative	267,160	$2.12	$566,379	267,160	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.